Back/Gilson Launches PIPETMAX® Systems to Transform Laboratory Automation and Workflows
tech·February 27, 2026·ngs

Gilson Launches PIPETMAX® Systems to Transform Laboratory Automation and Workflows

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • Gilson introduces PIPETMAX® 268 and 278 systems to streamline laboratory automation for qPCR, NGS, and bioassays.
  • The systems reduce implementation complexity and support laboratories in scaling routine applications with precision and reliability.
  • Gilson's ongoing expert support enhances user experience and adaptability of the new automation tools in laboratory settings.

Gilson Unveils New PIPETMAX® Systems to Revolutionize Laboratory Automation

Gilson, a pioneer in laboratory automation for over five decades, introduces its latest application-configured PIPETMAX® systems aimed at refining laboratory workflows across key scientific processes. The new PIPETMAX® 268 and PIPETMAX® 278 systems offer streamlined automation for quantitative PCR (qPCR), next-generation sequencing (NGS), and plate-based bioassays. This innovation is designed with specific workflows in mind, significantly reducing implementation complexity while enabling laboratories to scale their routine applications with precision and reliability. The introduction of these automated systems marks a critical advancement in laboratory settings, alleviating the common challenges associated with manual processes.

The PIPETMAX® 268 serves as a compact liquid handler, providing a space-efficient solution suited for smaller labs, whereas the PIPETMAX® 278 brings enhanced flexibility and increased throughput for larger operations. Both systems integrate optimized hardware and guided software assistance that support a smoother onboarding process for laboratory teams. This realistic deployment strategy allows scientists to automate essential tasks without requiring extensive engineering skills, paving the way for consistent and reproducible results right from the start. Dr. Jacqueline Rippington, Automation Product Marketing Manager at Gilson, emphasizes that the goal is to simplify automation and remove the uncertainty, making it possible for scientists to focus on their research without worrying about the underlying technology.

Key benefits of the PIPETMAX® systems include immediately usable validated methods, which greatly reduce setup time and operational difficulties. The inclusion of workflow wizards further demystifies complex procedures, providing laboratory teams with scalable options specifically tailored to their distinct throughput and complexity requirements. Gilson's commitment to ongoing support from their scientific experts ensures that teams are not only equipped to use the new systems effectively but also to adapt as their needs evolve. As laboratory automation continues to transform scientific workflows, Gilson’s innovative solutions position themselves as vital tools in enhancing laboratory efficiency and accuracy.

In conjunction with the introduction of the PIPETMAX® systems, Gilson invites interested parties to explore its new application center, where they can receive expert guidance on harnessing the full potential of these automation tools. With this major step forward, Gilson reiterates its unwavering commitment to advancing laboratory automation technology, thereby contributing to the broader scientific community's pursuit of improved research outcomes.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...